際際滷

際際滷Share a Scribd company logo
Blood Transfusion Project
Reducing Transfusion in the MARCQI Population
Anemia in Healthy Awake
Volunteers
 Critical hemoglobin threshold unknown in humans
 At 6 g/dL
 Decline in cognitive function
 At 5 g/dL
 VO2 maintained
 ST changes in 5%
 Memory formation impaired
Lieberman, et al. Anesthesiology 2000
Risks of Blood Transfusion
 Viral transmission
 Acute transfusion reactions
 Immunosuppression
 Acute inflammatory response
Noninfectious Hazards Immunosuppression
Infection
Age of Stored Blood
Hovav et al. Transfusion. 1999; 39: 277-281.
Williamson LM, et al. BMJ. 1999;319:16-9.
Serious Hazards of Transfusion
Based on 366 spontaneously-reported
deaths/major complications between
October 1996 and September 1998
in the UK and Ireland.
Transfusion-transmitted
infections
Acute lung injury
Post-transfusion
purpura
Graft vs host
disease
Delayed
transfusion
reaction
Acute
transfusion
reaction
Incorrect blood/
component
transfused
3%
6%
8%
2%
14%
15%
53%
Immune Effects of Blood
 Decreased T-cell proliferation
 Decreased CD3, CD4, CD8 T-cells
 Increased Cell-mediated lympholysis
 Increased TNF-alpha
 Increased suppressor T-cell activity
 Reduced natural killer cell activity
McAlister FA, et al, British Journal of Surgery 1998; 85: 171-178
Innerhofer et al. Transfusion 1999 Oct;39(10):1089
TRIM  Transfusion-associated Immunomodulation
Blood Transfusion Increases
Risk of Postoperative
Bacterial Infection
 20 peer-reviewed studies, 1986-2000
 13,152 patients
 5215 transfused
 7937 not transfused
 Association of Transfusion to Infection
 OR 3.45 (range 1.43-15.15)
 17 of 20 studies with p < 0.05
Hill GE, Minei JP et al. J Trauma 2003;54:908-914
Predictors and Complications of
Blood Transfusion in Total Hip and
Knee Arthroplasty
 Henry Ford Hospital
 Jan 2011 to Dec 2012
 1573 patients
 13.3% higher infection rate in transfused patients
 Factors associated with transfusion
 Age
 Female gender
 BMI
Frisch, et al. AAHKS 11/2013
The TRICC Study
Herbert PC, et al. NEJM 1999
 838 patients ICU patients
 Placed into one of two groups
 Restrictive group:
 Transfuse if Hb < 7
 Maintain between 7 and 9
 Liberal group:
 Transfuse if Hb < 10
 Maintain between 10 and 12
 The primary outcome measure was death from all causes in
the 30 days after randomization
The TRICC Study
8.7% vs 16.1% 5.7% vs 13.0%
Herbert PC, et al. NEJM 1999
CRIT Study
4,892 ICU patients in the US
Prospective, multiple center, observational
cohort
Examine the relationship of
Anemia
RBC transfusion
Clinical outcomes
Crit Care Med. 2004 Jan;32(1):39-52
CRIT Results
35% of Blood transfused
in patients with Hgb  9
Crit Care Med. 2004 Jan;32(1):39-52
CRIT Results
RBC transfusion was independently
associated with higher mortality
OR 1.65 (CI 1.35-2.03)
OR 2.62 if 3-4 units
transfused
Crit Care Med. 2004 Jan;32(1):39-52
0
1
2
3-5
 6
Ann Thorac Surg 2006;81:1650 7
FOCUS Trial
 Inclusion criteria:
 Undergo surgery for hip fracture
 Have a history of cardiovascular disease
 Have a postoperative Hgb < 10 g/dL
 Randomized to keep Hgb > 10 g/dL or not
 Primary outcome
 Ability to walk 10 feet without assistance at 60 days
 Negative outcomes
 Postoperative unstable angina
 Myocardial infarction
 Death
N Engl J Med 2011;365:2453-62.
Financial Burden
$11.08 $10.76
$12.56 $12.56
$14.97
$0
$5
$10
$15
$20
FY'04 FY'05 FY'06 FY'07 FY'08
UMHHC direct cost of blood
products
Millions
Exploring Surgery Level Risk
Factors for Transfusion and
Readmission
General versus regional anesthesia
Hip Knee
Time in OR by hospital
Hip Knee
Minutes
Hospital Hospital
Use of Tranexemic Acid
Hip Knee
Associations of surgical variables with outcome
for hip arthroplasty
Variable Blood Transfusion Readmission
RR (95% CI) RR (95% CI)
Anesthesia General versus Regional 1.30 (0.921.86) 1.53 (1.181.97)
Operative Approach
Anterolateral versus Posterior 1.52 (1.211.90) # 0.88 (0.671.14)
Anterior versus Posterior 0.82 (0.302.23) 1.22 (0.761.96)
Tranexemic Acid 0.64 (0.440.93) 1.10 (0.931.29)
15 Minutes of OR time 1.04 (0.971.11)
Blood Transfusion 1.20 (1.091.33)
# Interpret with caution
Associations of surgical variables with outcome
for knee arthroplasty
Variable Blood Transfusion Readmission
RR (95% CI) RR (95% CI)
Anesthesia General versus Regional 1.38(1.031.84) 1.15 (0.831.61)
Operative Approach
MPK vs SVK 1.12 (0.801.59) 1.02 (0.871.20)
MVK vs SVK 0.79 (0.611.02) 1.01 (0.871.17)
Tranexemic Acid 0.85 (0.581.25) 0.90 (0.721.11)
15 Minutes of OR time 1.11 (1.071.16)
Blood Transfusion 1.27 (1.081.50)
Crude and adjusted risk of blood transfusion
for hip arthroplasty by MARCQI site
Rate
of
Transfusion
Hospital
Crude and adjusted risk of blood transfusion
for knee arthroplasty by MARCQI site
Rate
of
Transfusion
Hospital
Allogenic Transfusion
 Risks
 Disease transmission
 Increased complication rates
 Increased readmissions (MARCQI data)
 Increased mortality
MARCQI Transfusion Data
 9.8% of MARCQI patients are transfused
 14.2% of hips
 7% of knees
 23% of bilateral knees
 Only 1.5% of patients have nadir Hgb < 7 g/dL
 4.6% receive TXA
MARCQI Sites:
Transfusion Guidelines
 Wide range of transfusion triggers
 Some have no protocol
 Asymptomatic patient
 Hgb < 7 g/dL to Hgb < 9 g/dL
 Symptomatic patients
 Hgb < 7 g/dL to Hgb < 11 g/dL
U of M Transfusion
Guidelines
 Hgb < 6 g/dL in asymptomatic patient
 Hbg < 7 g/dL in post-op or ill patient
 Hgb < 10 g/dL acute coronary syndrome
Restrictive Transfusion
Protocols
 Are safe
 Recommended by:
 American Red Cross (ARC)
 American Association of Blood Banks (AABB)
 Cochrane Collaboration Review
Summary
 Transfusion may benefit patients during acute
coronary syndromes if Hgb < 8-10 g/dL
 There is very rarely an indication to transfuse ANY
patient with a Hbg  10 g/dL
 Each unit incrementally increases risk
 Decreasing transfusion may
 reduce risk of infection and readmission
 reduce mortality
 decrease cost
Guidelines for Blood
Transfusion: PRBCs
 These guidelines are intended to ensure that the
most appropriate, efficient and safe use of the
blood supply is achieved
 To establish evidence-based criteria for the
transfusion of blood components
 Every indication for the use of blood products
cannot be anticipated
 These guidelines are not intended to override
physician judgement
Guidelines for Blood
Transfusion: PRBCs
 Administered as single units except for ongoing
blood loss with hemodynamic instability.
 Transfusion decisions are clinical judgments that
should not be based on laboratory parameters
alone.
Transfusion Guidelines
 Red Cross Transfusion Guidelines
 Post-operative patients
 Indications for allogenic transfusion
 Threshold of Hgb < 8 g/dL
 Clinically significant symptoms of anemia
 Unresponsive to fluid resuscitation
 Clinical judgement in patients with
Hgb < 10 g/dL and increased risk factors
MARCQI recommendation
 Encourage adoption of the Red
Cross Guidelines or similar
protocols at your institution and in
your practice
 Transfuse one unit at a time
 Encourage these practices with
your colleagues
Tranexamic Acid
 Low numbers in MARCQI
 Associated with reduced transfusion in hips
 Concerns over risks
 Increasing support in literature
 Will continue to monitor
Ad

Recommended

Blood Transfusion in ICU
Blood Transfusion in ICU
Sherif Elbadrawy
11 surgical bleeding and transfusions
11 surgical bleeding and transfusions
Dang Thanh Tuan
Blood Transfusion: Rethinking who, what and when
Blood Transfusion: Rethinking who, what and when
SCGH ED CME
Blood transfusion trigger. Time for new Triccs
Blood transfusion trigger. Time for new Triccs
swethaguru4
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr Garc鱈a Erce. Roma 2015
PBM. MANEJO DE LA ANEMIA PREOPERATORIA. Dr Garc鱈a Erce. Roma 2015
Jos辿 Antonio Garc鱈a Erce
PBM. Preoperative Anemia Management, Dr Garc鱈a Erce. Roma 2015
PBM. Preoperative Anemia Management, Dr Garc鱈a Erce. Roma 2015
Jos辿 Antonio Garc鱈a Erce
Foukaneli transfusion support for haem pts.ppt
Foukaneli transfusion support for haem pts.ppt
urmi61
Blood transfusion
Blood transfusion
Ghadah Sidqi Qumsan
Physiological triggers for blood transfusion in the icu
Physiological triggers for blood transfusion in the icu
chandra talur
Blood Conservation
Blood Conservation
pprashant00
Why give 2 when 1 will do
Why give 2 when 1 will do
Lynstar1
Blood & blood products in icu
Blood & blood products in icu
imran80
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
ShantanuChowdhury71
Patient Blood Management
Patient Blood Management
Mathurange Krishnapillai
Transfusion therapy
Transfusion therapy
Dr.sajid Nomani
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
ashishnair22
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
Jos辿 Antonio Garc鱈a Erce
Transfusion trials in medicine world.pptx
Transfusion trials in medicine world.pptx
shanekenanga
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
Final ppt.pptx- perioperative blood transfusion guidelines
Final ppt.pptx- perioperative blood transfusion guidelines
Anuradha239875
Transfusion trigger in Intensive Care Unit
Transfusion trigger in Intensive Care Unit
Yazan Kherallah
Blood component transfusion in criticalcare now
Blood component transfusion in criticalcare now
Muhammad Akram
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
doctor / pediatrician
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
Jos辿 Antonio Garc鱈a Erce
A predictive model to reduce allogenic transfusions in primary total hip arth...
A predictive model to reduce allogenic transfusions in primary total hip arth...
anemo_site
Blood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practice
Ibrahim khidir ibrahim osman
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatible
Bharath T
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
SKGAMING32
527751381-Parkinson-Disease-際際滷s (1).pdf
527751381-Parkinson-Disease-際際滷s (1).pdf
SKGAMING32

More Related Content

Similar to marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE (20)

Physiological triggers for blood transfusion in the icu
Physiological triggers for blood transfusion in the icu
chandra talur
Blood Conservation
Blood Conservation
pprashant00
Why give 2 when 1 will do
Why give 2 when 1 will do
Lynstar1
Blood & blood products in icu
Blood & blood products in icu
imran80
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
ShantanuChowdhury71
Patient Blood Management
Patient Blood Management
Mathurange Krishnapillai
Transfusion therapy
Transfusion therapy
Dr.sajid Nomani
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
ashishnair22
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
Jos辿 Antonio Garc鱈a Erce
Transfusion trials in medicine world.pptx
Transfusion trials in medicine world.pptx
shanekenanga
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
Final ppt.pptx- perioperative blood transfusion guidelines
Final ppt.pptx- perioperative blood transfusion guidelines
Anuradha239875
Transfusion trigger in Intensive Care Unit
Transfusion trigger in Intensive Care Unit
Yazan Kherallah
Blood component transfusion in criticalcare now
Blood component transfusion in criticalcare now
Muhammad Akram
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
doctor / pediatrician
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
Jos辿 Antonio Garc鱈a Erce
A predictive model to reduce allogenic transfusions in primary total hip arth...
A predictive model to reduce allogenic transfusions in primary total hip arth...
anemo_site
Blood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practice
Ibrahim khidir ibrahim osman
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatible
Bharath T
Physiological triggers for blood transfusion in the icu
Physiological triggers for blood transfusion in the icu
chandra talur
Blood Conservation
Blood Conservation
pprashant00
Why give 2 when 1 will do
Why give 2 when 1 will do
Lynstar1
Blood & blood products in icu
Blood & blood products in icu
imran80
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
PPTX ON RETRIVE TRANSFUSION PROTOCOL 2.pptx
ShantanuChowdhury71
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
TRICC TRIAL AND OTHER TRANSFUSION TRIGGERS.pptx
ashishnair22
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
INTRODUCCIN AL PATIENT BLOOD MANAGEMENT. Conferencia Inagural. Prof Herrera
Jos辿 Antonio Garc鱈a Erce
Transfusion trials in medicine world.pptx
Transfusion trials in medicine world.pptx
shanekenanga
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
Final ppt.pptx- perioperative blood transfusion guidelines
Final ppt.pptx- perioperative blood transfusion guidelines
Anuradha239875
Transfusion trigger in Intensive Care Unit
Transfusion trigger in Intensive Care Unit
Yazan Kherallah
Blood component transfusion in criticalcare now
Blood component transfusion in criticalcare now
Muhammad Akram
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
Indications for Blood Transfusion and Audit of GP Transfusion Practice.pdf
doctor / pediatrician
Why give 2 when 1 will do final
Why give 2 when 1 will do final
Lynstar1
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
PATIENT BLOOD MANAGEMENT Dr Garcia Erce Mediterranean Anaemia Course4th cong...
Jos辿 Antonio Garc鱈a Erce
A predictive model to reduce allogenic transfusions in primary total hip arth...
A predictive model to reduce allogenic transfusions in primary total hip arth...
anemo_site
Blood transfusion guidelines in clinical practice
Blood transfusion guidelines in clinical practice
Ibrahim khidir ibrahim osman
Red cell transfusions in the critically ill compatible
Red cell transfusions in the critically ill compatible
Bharath T

More from SKGAMING32 (10)

hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
SKGAMING32
527751381-Parkinson-Disease-際際滷s (1).pdf
527751381-Parkinson-Disease-際際滷s (1).pdf
SKGAMING32
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
SKGAMING32
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
SKGAMING32
Total protein in serum_20241110_145525_0000.pdf
Total protein in serum_20241110_145525_0000.pdf
SKGAMING32
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
SKGAMING32
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
SKGAMING32
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
SKGAMING32
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
SKGAMING32
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
SKGAMING32
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
SKGAMING32
527751381-Parkinson-Disease-際際滷s (1).pdf
527751381-Parkinson-Disease-際際滷s (1).pdf
SKGAMING32
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
SKGAMING32
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
SKGAMING32
Total protein in serum_20241110_145525_0000.pdf
Total protein in serum_20241110_145525_0000.pdf
SKGAMING32
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
SKGAMING32
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
SKGAMING32
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
SKGAMING32
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
SKGAMING32
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
SKGAMING32
Ad

Recently uploaded (20)

strees management for iuyagvdywyyqwdghuvuy.pptx
strees management for iuyagvdywyyqwdghuvuy.pptx
moonahish27
Quectel M10 AT commands Arduino Microcontroller
Quectel M10 AT commands Arduino Microcontroller
AdamSunusiHaruna1
The_Geometry_of_Natshshshshshsbsure.pptx
The_Geometry_of_Natshshshshshsbsure.pptx
sambal5
I2C EEPROM SIMULATION IN VERILOG-12.pptx
I2C EEPROM SIMULATION IN VERILOG-12.pptx
sudheerkurakula1218
Formal Informal Apology letter.pptxvvvvv
Formal Informal Apology letter.pptxvvvvv
iqlimajurayeva
GOV. Incentives for ED[1][1][1].pptx [Read-Only].pptx
GOV. Incentives for ED[1][1][1].pptx [Read-Only].pptx
kunalArora758765
Presentation.pptx tinkercadjajsjhdhdhdhs
Presentation.pptx tinkercadjajsjhdhdhdhs
sukh27012
Aimee White Visual Thinking, Graphic Design, Livermore
Aimee White Visual Thinking, Graphic Design, Livermore
aimeewhite13
Clamp_and_bend_device_exercisee_DSD.pptx
Clamp_and_bend_device_exercisee_DSD.pptx
DhanushJCS1
brain anatomy physiology 2025 short.pptx
brain anatomy physiology 2025 short.pptx
MohamedHany892810
3 bedroom bungalow and all bedrooms ensuite
3 bedroom bungalow and all bedrooms ensuite
modele dawodu
honor-cert-quarter -1 for template .pptx
honor-cert-quarter -1 for template .pptx
DanteJrBitoon
Numbers 1 to 100 Circle Flashcard s.pptx
Numbers 1 to 100 Circle Flashcard s.pptx
KarenGimena1
Sir Norman Foster Philip Jodidio TASCHEN
Sir Norman Foster Philip Jodidio TASCHEN
FernandoMondragon14
Assignment 1_ studying a roomkjdhfkeqjdhfjeqhfdjkqebf
Assignment 1_ studying a roomkjdhfkeqjdhfjeqhfdjkqebf
kunduanannya2003
FLOURISHING THROUGH SENSES: FROM AbSENSE to PreSENSE to EsSENSE to Re-...
FLOURISHING THROUGH SENSES: FROM AbSENSE to PreSENSE to EsSENSE to Re-...
Samuel Thuo
Genting Kecamatan Samadua Tahun 2025.pptx
Genting Kecamatan Samadua Tahun 2025.pptx
fazrulichsanmilan
animewitcher.cc https://animewitcher.cc/
animewitcher.cc https://animewitcher.cc/
Anime witcher
User Persona for a fitness CEO Founder
User Persona for a fitness CEO Founder
modele dawodu
the sigma cafe a b c d e f g h i j k l i
the sigma cafe a b c d e f g h i j k l i
kamalpavlov
strees management for iuyagvdywyyqwdghuvuy.pptx
strees management for iuyagvdywyyqwdghuvuy.pptx
moonahish27
Quectel M10 AT commands Arduino Microcontroller
Quectel M10 AT commands Arduino Microcontroller
AdamSunusiHaruna1
The_Geometry_of_Natshshshshshsbsure.pptx
The_Geometry_of_Natshshshshshsbsure.pptx
sambal5
I2C EEPROM SIMULATION IN VERILOG-12.pptx
I2C EEPROM SIMULATION IN VERILOG-12.pptx
sudheerkurakula1218
Formal Informal Apology letter.pptxvvvvv
Formal Informal Apology letter.pptxvvvvv
iqlimajurayeva
GOV. Incentives for ED[1][1][1].pptx [Read-Only].pptx
GOV. Incentives for ED[1][1][1].pptx [Read-Only].pptx
kunalArora758765
Presentation.pptx tinkercadjajsjhdhdhdhs
Presentation.pptx tinkercadjajsjhdhdhdhs
sukh27012
Aimee White Visual Thinking, Graphic Design, Livermore
Aimee White Visual Thinking, Graphic Design, Livermore
aimeewhite13
Clamp_and_bend_device_exercisee_DSD.pptx
Clamp_and_bend_device_exercisee_DSD.pptx
DhanushJCS1
brain anatomy physiology 2025 short.pptx
brain anatomy physiology 2025 short.pptx
MohamedHany892810
3 bedroom bungalow and all bedrooms ensuite
3 bedroom bungalow and all bedrooms ensuite
modele dawodu
honor-cert-quarter -1 for template .pptx
honor-cert-quarter -1 for template .pptx
DanteJrBitoon
Numbers 1 to 100 Circle Flashcard s.pptx
Numbers 1 to 100 Circle Flashcard s.pptx
KarenGimena1
Sir Norman Foster Philip Jodidio TASCHEN
Sir Norman Foster Philip Jodidio TASCHEN
FernandoMondragon14
Assignment 1_ studying a roomkjdhfkeqjdhfjeqhfdjkqebf
Assignment 1_ studying a roomkjdhfkeqjdhfjeqhfdjkqebf
kunduanannya2003
FLOURISHING THROUGH SENSES: FROM AbSENSE to PreSENSE to EsSENSE to Re-...
FLOURISHING THROUGH SENSES: FROM AbSENSE to PreSENSE to EsSENSE to Re-...
Samuel Thuo
Genting Kecamatan Samadua Tahun 2025.pptx
Genting Kecamatan Samadua Tahun 2025.pptx
fazrulichsanmilan
animewitcher.cc https://animewitcher.cc/
animewitcher.cc https://animewitcher.cc/
Anime witcher
User Persona for a fitness CEO Founder
User Persona for a fitness CEO Founder
modele dawodu
the sigma cafe a b c d e f g h i j k l i
the sigma cafe a b c d e f g h i j k l i
kamalpavlov
Ad

marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE

  • 1. Blood Transfusion Project Reducing Transfusion in the MARCQI Population
  • 2. Anemia in Healthy Awake Volunteers Critical hemoglobin threshold unknown in humans At 6 g/dL Decline in cognitive function At 5 g/dL VO2 maintained ST changes in 5% Memory formation impaired Lieberman, et al. Anesthesiology 2000
  • 3. Risks of Blood Transfusion Viral transmission Acute transfusion reactions Immunosuppression Acute inflammatory response Noninfectious Hazards Immunosuppression Infection
  • 4. Age of Stored Blood Hovav et al. Transfusion. 1999; 39: 277-281.
  • 5. Williamson LM, et al. BMJ. 1999;319:16-9. Serious Hazards of Transfusion Based on 366 spontaneously-reported deaths/major complications between October 1996 and September 1998 in the UK and Ireland. Transfusion-transmitted infections Acute lung injury Post-transfusion purpura Graft vs host disease Delayed transfusion reaction Acute transfusion reaction Incorrect blood/ component transfused 3% 6% 8% 2% 14% 15% 53%
  • 6. Immune Effects of Blood Decreased T-cell proliferation Decreased CD3, CD4, CD8 T-cells Increased Cell-mediated lympholysis Increased TNF-alpha Increased suppressor T-cell activity Reduced natural killer cell activity McAlister FA, et al, British Journal of Surgery 1998; 85: 171-178 Innerhofer et al. Transfusion 1999 Oct;39(10):1089 TRIM Transfusion-associated Immunomodulation
  • 7. Blood Transfusion Increases Risk of Postoperative Bacterial Infection 20 peer-reviewed studies, 1986-2000 13,152 patients 5215 transfused 7937 not transfused Association of Transfusion to Infection OR 3.45 (range 1.43-15.15) 17 of 20 studies with p < 0.05 Hill GE, Minei JP et al. J Trauma 2003;54:908-914
  • 8. Predictors and Complications of Blood Transfusion in Total Hip and Knee Arthroplasty Henry Ford Hospital Jan 2011 to Dec 2012 1573 patients 13.3% higher infection rate in transfused patients Factors associated with transfusion Age Female gender BMI Frisch, et al. AAHKS 11/2013
  • 9. The TRICC Study Herbert PC, et al. NEJM 1999 838 patients ICU patients Placed into one of two groups Restrictive group: Transfuse if Hb < 7 Maintain between 7 and 9 Liberal group: Transfuse if Hb < 10 Maintain between 10 and 12 The primary outcome measure was death from all causes in the 30 days after randomization
  • 10. The TRICC Study 8.7% vs 16.1% 5.7% vs 13.0% Herbert PC, et al. NEJM 1999
  • 11. CRIT Study 4,892 ICU patients in the US Prospective, multiple center, observational cohort Examine the relationship of Anemia RBC transfusion Clinical outcomes Crit Care Med. 2004 Jan;32(1):39-52
  • 12. CRIT Results 35% of Blood transfused in patients with Hgb 9 Crit Care Med. 2004 Jan;32(1):39-52
  • 13. CRIT Results RBC transfusion was independently associated with higher mortality OR 1.65 (CI 1.35-2.03) OR 2.62 if 3-4 units transfused Crit Care Med. 2004 Jan;32(1):39-52
  • 14. 0 1 2 3-5 6 Ann Thorac Surg 2006;81:1650 7
  • 15. FOCUS Trial Inclusion criteria: Undergo surgery for hip fracture Have a history of cardiovascular disease Have a postoperative Hgb < 10 g/dL Randomized to keep Hgb > 10 g/dL or not Primary outcome Ability to walk 10 feet without assistance at 60 days Negative outcomes Postoperative unstable angina Myocardial infarction Death
  • 16. N Engl J Med 2011;365:2453-62.
  • 17. Financial Burden $11.08 $10.76 $12.56 $12.56 $14.97 $0 $5 $10 $15 $20 FY'04 FY'05 FY'06 FY'07 FY'08 UMHHC direct cost of blood products Millions
  • 18. Exploring Surgery Level Risk Factors for Transfusion and Readmission
  • 19. General versus regional anesthesia Hip Knee
  • 20. Time in OR by hospital Hip Knee Minutes Hospital Hospital
  • 21. Use of Tranexemic Acid Hip Knee
  • 22. Associations of surgical variables with outcome for hip arthroplasty Variable Blood Transfusion Readmission RR (95% CI) RR (95% CI) Anesthesia General versus Regional 1.30 (0.921.86) 1.53 (1.181.97) Operative Approach Anterolateral versus Posterior 1.52 (1.211.90) # 0.88 (0.671.14) Anterior versus Posterior 0.82 (0.302.23) 1.22 (0.761.96) Tranexemic Acid 0.64 (0.440.93) 1.10 (0.931.29) 15 Minutes of OR time 1.04 (0.971.11) Blood Transfusion 1.20 (1.091.33) # Interpret with caution
  • 23. Associations of surgical variables with outcome for knee arthroplasty Variable Blood Transfusion Readmission RR (95% CI) RR (95% CI) Anesthesia General versus Regional 1.38(1.031.84) 1.15 (0.831.61) Operative Approach MPK vs SVK 1.12 (0.801.59) 1.02 (0.871.20) MVK vs SVK 0.79 (0.611.02) 1.01 (0.871.17) Tranexemic Acid 0.85 (0.581.25) 0.90 (0.721.11) 15 Minutes of OR time 1.11 (1.071.16) Blood Transfusion 1.27 (1.081.50)
  • 24. Crude and adjusted risk of blood transfusion for hip arthroplasty by MARCQI site Rate of Transfusion Hospital
  • 25. Crude and adjusted risk of blood transfusion for knee arthroplasty by MARCQI site Rate of Transfusion Hospital
  • 26. Allogenic Transfusion Risks Disease transmission Increased complication rates Increased readmissions (MARCQI data) Increased mortality
  • 27. MARCQI Transfusion Data 9.8% of MARCQI patients are transfused 14.2% of hips 7% of knees 23% of bilateral knees Only 1.5% of patients have nadir Hgb < 7 g/dL 4.6% receive TXA
  • 28. MARCQI Sites: Transfusion Guidelines Wide range of transfusion triggers Some have no protocol Asymptomatic patient Hgb < 7 g/dL to Hgb < 9 g/dL Symptomatic patients Hgb < 7 g/dL to Hgb < 11 g/dL
  • 29. U of M Transfusion Guidelines Hgb < 6 g/dL in asymptomatic patient Hbg < 7 g/dL in post-op or ill patient Hgb < 10 g/dL acute coronary syndrome
  • 30. Restrictive Transfusion Protocols Are safe Recommended by: American Red Cross (ARC) American Association of Blood Banks (AABB) Cochrane Collaboration Review
  • 31. Summary Transfusion may benefit patients during acute coronary syndromes if Hgb < 8-10 g/dL There is very rarely an indication to transfuse ANY patient with a Hbg 10 g/dL Each unit incrementally increases risk Decreasing transfusion may reduce risk of infection and readmission reduce mortality decrease cost
  • 32. Guidelines for Blood Transfusion: PRBCs These guidelines are intended to ensure that the most appropriate, efficient and safe use of the blood supply is achieved To establish evidence-based criteria for the transfusion of blood components Every indication for the use of blood products cannot be anticipated These guidelines are not intended to override physician judgement
  • 33. Guidelines for Blood Transfusion: PRBCs Administered as single units except for ongoing blood loss with hemodynamic instability. Transfusion decisions are clinical judgments that should not be based on laboratory parameters alone.
  • 34. Transfusion Guidelines Red Cross Transfusion Guidelines Post-operative patients Indications for allogenic transfusion Threshold of Hgb < 8 g/dL Clinically significant symptoms of anemia Unresponsive to fluid resuscitation Clinical judgement in patients with Hgb < 10 g/dL and increased risk factors
  • 35. MARCQI recommendation Encourage adoption of the Red Cross Guidelines or similar protocols at your institution and in your practice Transfuse one unit at a time Encourage these practices with your colleagues
  • 36. Tranexamic Acid Low numbers in MARCQI Associated with reduced transfusion in hips Concerns over risks Increasing support in literature Will continue to monitor